Recent Major Changes Indications and Usage for Vyvanse VYVANSE is a central nervous system (CNS) stimulant indicated for the treatment of (1): Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older Moderate to severe binge eating disorder (BED) in adults Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage (5.5, 8.4) VYVANSE is not indicated for weight loss
Ozempic and Crohn's Disease: Safety, Risks and Considerations Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for treating type 2 diabetes mellitus
Han KH, Lim S, Ryu J, et al
The cDNA fragments were ligated into the pGADT7 cloning vector as prey proteins, and were co-transformed into yeast competent cell Y187
And liability does not stop with the prescribing physician
If youre stuck between the two, or just hearing about them for the first time, heres the breakdownwhat they do, how theyre different, and what might actually work for you